Jon Hanifin, MD
Enriched profileProfessor Emeritus, Department of Dermatology · Oregon Health & Science University (OHSU)
Jon Hanifin is Professor Emeritus, Department of Dermatology at Oregon Health & Science University (OHSU). OpenAlex indexes 367 publications with 35,488 citations (h-index 87); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Dermatology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Jon M. Hanifin, MD, is Professor Emeritus, Department of Dermatology at Oregon Health & Science University (OHSU). The public record shows 367 publications with 35,488 citations (h-index 87), centered on Atopic Dermatitis / Eczema. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 1 companies, 5 NIH-funded awards (1985–2001).
- Top research focus: Atopic Dermatitis / Eczema
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Immune Response to Yellow Fever Vaccination in Adults With Atopic Dermatitis
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Industry payments
Updated 27 Aug 2026
1 company reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20212 payments
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
100%Interleukin-4 Receptor alpha Antagonist100%Dupixent Syringe100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
5 NIH research awards on record, funded 1985–2001 per NIH RePORTER. The latest:
- International Symposium on Atopic Dermatitis
National Eczema Assn for Science &educ
FY2001$20,000R13AR047528 - DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF CTLA4IG IN PATIENTS WITH PSORIASIS
Oregon Health and Science University
FY1999M01RR000334 - DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF CTLA4IG IN PATIENTS WITH PSORIASIS
Oregon Health and Science University
FY1998M01RR000334
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study
Journal of Allergy and Clinical Immunology
2018 - Patients with Atopic Dermatitis Colonized with Staphylococcus aureus Have a Distinct Phenotype and Endotype
Journal of Investigative Dermatology
2018 - What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study
British Journal of Dermatology
2015
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/profile/Jon-Hanifin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
pubmed.ncbi.nlm.nih.gov/30891849
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pubmed.ncbi.nlm.nih.gov ↗ - Other
ohsu.edu/providers/jon-m-hanifin/1A322BDFBD4C4FC1BAB7F531855CAABE
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ohsu.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
- Board Certified
American Board of Dermatology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
Editorial & leadership roles
journal and society appointments- International Advisory Board member
The Journal of Dermatology (Wiley)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onlinelibrary.wiley.com ↗
Awards & honors
honors on the public record- 2023 David Martin Carter Mentor Award
American Skin Association, for exceptional contributions to the study of atopic diseases
2023verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →americanskin.org ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pubmed.ncbi.nlm.nih.gov ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jonathan Purnell, MD
Oregon Health & Science University (OHSU)
Shivaani Kummar, MD
Oregon Health & Science University (OHSU)
Charles Blanke, MD
Oregon Health & Science University (OHSU)